What actually happens when a dog develops spleen cancer?

The spleen is a fist-to-forearm-sized organ that filters blood, recycles old red blood cells, and helps the immune system respond to infection. When splenic cells divide abnormally, they can form a mass that is either benign, such as a hematoma or nodular hyperplasia, or malignant, most commonly hemangiosarcoma, a fast-growing cancer of blood vessel lining cells. Cornell University's Riney Canine Health Center notes that hemangiosarcoma accounts for a large share of malignant splenic tumors and is notorious for spreading to the liver, lungs, and heart before it is ever detected (Cornell Riney Canine Health Center, n.d.).

Because the spleen has a rich blood supply and considerable capacity to expand, tumors can reach several inches across before an owner or even a vet notices anything wrong on a routine exam. Studies summarized by veterinary oncology groups estimate that about two-thirds of masses found in the spleen are malignant, and hemangiosarcoma alone makes up a substantial portion of those cases (American College of Veterinary Internal Medicine, n.d.). That statistic is central to why any splenic mass in an older dog is treated as a medical emergency until biopsy proves otherwise.

What are the first signs that something is wrong?

In the early stages, most dogs show nothing at all, which is part of what makes this disease so dangerous. Owners who do notice something usually describe vague changes: a dog that seems a little more tired than usual, eats less enthusiastically, or has one or two episodes of wobbliness that resolve on their own within minutes. These brief weakness episodes happen when a slow leak of blood from the tumor temporarily drops blood pressure, then the body compensates and the dog seems to bounce back, according to Merck Veterinary Manual (Merck Veterinary Manual, 2024).

The more dramatic presentation comes when the tumor ruptures outright. Affected dogs can develop pale or white gums, a rapid heart rate, a swollen or fluid-filled abdomen, and sudden collapse from internal bleeding into the abdominal cavity. Merck Veterinary Manual describes this hemoabdomen scenario as a true emergency requiring immediate stabilization, since blood loss into the belly can be severe enough to cause hypovolemic shock within a short window (Merck Veterinary Manual, 2024).

Which dogs are most at risk, and is there a genetic component?

Splenic tumors, and hemangiosarcoma in particular, are seen far more often in large and giant breeds in their senior years, typically dogs over 8 years old. Golden Retrievers, German Shepherd Dogs, Labrador Retrievers, Portuguese Water Dogs, and Boxers show up repeatedly in breed-risk studies, and the AKC Canine Health Foundation has funded genetic research specifically because hemangiosarcoma appears clustered in certain lines within these breeds (AKC Canine Health Foundation, n.d.).

Age is the single strongest risk factor identified across studies, with median age at diagnosis commonly falling between 9 and 12 years. Sex differences are less consistent than breed differences, though some studies note a modest predisposition in males. No dietary or lifestyle cause has been conclusively established, so genetics and breed background remain the primary risk markers vets rely on when advising owners of at-risk breeds to watch for subtle changes (Cornell Riney Canine Health Center, n.d.).

How do vets figure out if a splenic mass is cancer?

Diagnosis typically starts with abdominal ultrasound, which can identify a mass in the spleen and check for fluid in the abdomen or spread to the liver within minutes of a dog arriving at the clinic. Vets often follow this with a complete blood count, since dogs bleeding from a splenic tumor frequently show anemia and low platelet counts, plus a coagulation panel to rule out clotting disorders like DIC that can develop alongside hemangiosarcoma (Merck Veterinary Manual, 2024).

A chest X-ray series, sometimes three views, is standard before surgery to look for metastasis to the lungs, since finding spread there changes the conversation about whether surgery will meaningfully help. Definitive diagnosis, however, only comes from histopathology of the removed spleen, because ultrasound and bloodwork alone cannot reliably distinguish a benign hematoma from hemangiosarcoma; that distinction matters enormously for prognosis and is why biopsy after splenectomy is considered the diagnostic gold standard (American College of Veterinary Internal Medicine, n.d.).

What treatment options actually help a dog with this diagnosis?

Splenectomy, surgical removal of the entire spleen, is the primary treatment for both benign and malignant splenic masses, and dogs tolerate losing the spleen well since the liver and other lymphoid tissue take over its functions. For dogs with a ruptured tumor and active bleeding, surgery is often performed on an emergency basis after initial stabilization with IV fluids and, in some cases, blood transfusion (Merck Veterinary Manual, 2024).

When histopathology confirms hemangiosarcoma, oncologists typically recommend chemotherapy afterward, most often a doxorubicin-based protocol given every two to three weeks for four to six treatments, because surgery alone leaves microscopic cancer cells behind in most cases. The AKC Canine Health Foundation notes that combining splenectomy with chemotherapy roughly doubles median survival time compared with surgery alone, though outcomes still vary widely by individual case and stage at diagnosis (AKC Canine Health Foundation, n.d.).

How do you care for a dog at home after spleen surgery?

Recovery from splenectomy generally involves 10 to 14 days of restricted activity, meaning leash walks only and no running, jumping, or stairs, while the abdominal incision heals. Owners are usually asked to monitor the incision daily for swelling, discharge, or gaping, and to watch appetite and energy closely in the first week, since a dog that stops eating or seems increasingly lethargic after going home needs a same-day recheck.

If chemotherapy is part of the plan, most dogs tolerate doxorubicin better than people tolerate chemo, with mild, manageable side effects like a day or two of low appetite or soft stool rather than severe illness, according to oncology guidance summarized by veterinary teaching hospitals (Cornell Riney Canine Health Center, n.d.). Routine bloodwork before each chemo session checks white blood cell counts to make sure the next dose is safe, and follow-up chest X-rays or ultrasounds are typically scheduled every two to three months afterward to watch for recurrence.

What is the realistic long-term outlook for a dog with spleen cancer?

Prognosis depends heavily on whether the tumor is benign or malignant and, if malignant, whether it has already spread. Dogs with benign splenic masses that are surgically removed generally go on to live a normal lifespan with no further treatment needed. Dogs diagnosed with hemangiosarcoma face a much harder road; median survival with splenectomy alone is commonly cited around 1 to 3 months, extending to roughly 4 to 6 months with the addition of chemotherapy, based on data summarized by veterinary oncology researchers (American College of Veterinary Internal Medicine, n.d.).

A small subset of dogs, sometimes reported around 10%, survive a year or longer, and newer treatments under investigation, including the drug eBAT and immunotherapy protocols studied through Cornell and other veterinary oncology centers, are being evaluated to see whether they can meaningfully extend that window (AKC Canine Health Foundation, n.d.). Because outcomes vary so much by individual case, owners are best served by a direct conversation with a veterinary oncologist about staging results and realistic expectations rather than relying on general averages alone.